Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Slides:

Advertisements

Similar presentations

Sven Haller Haller, Nguyen, Rodriguez, Emch, Gold, Bartsch, Lovblad, Giannakopoulos.

Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.

DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE Kathryn A. Wyman-Chick, Phillip.

Vladimir S. Fonov, Mahsa Dadar, Xiao Yiming, D. Louis Collins

Volume 3, Issue 4, Pages (November 2017)

Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study Wesley.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon

MTL SUBREGIONAL MORPHOMETRY USING HIGH RESOLUTION MRI IN ADNI2

Different pathways to Alzheimer’s disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES

Volume 3, Issue 2, Pages (June 2017)

Flora H. Duits, Niels D. Prins, Afina W. Lemstra, Yolande A. L

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Trajectory of multi-dimensional caregiving burden in chinese informal caregivers for dementia: Evidence from exploratory and confirmatory factor analysis.

The differential diagnosis of amnestic mild cognitive impairment and Alzheimer's disease dementia by hippocampal volume measurement with MR in a chinese.

Localization of Hippocampal atrophy in Alzheimer's disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints Argonde C. van Harten, Pieter Jelle Visser,

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design Arno de Wilde, Ingrid S. van Maurik, Marleen Kunneman, Femke Bouwman, Marissa.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Christine Bredfeldt, Kristen Rice, Lisa Alecxih

SMARTPHONE TECHNOLOGY TO MEASURE HEALTH CHARACTERISTICS IN OFFSPRING OF PATIENTS WITH DEMENTIA: THE IVITALITY PROOF-OF- PRINCIPLE STUDY Liselotte Wijsman,

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

The effect of using a conditional discrimination procedure to teach name-face relation to a person diagnosed with dementia Hanna S. Steingrimsdottir,

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Anna Caroli, Samantha Galluzzi, Clarissa Ferrari, Annapaola.

DATA-DRIVEN TAU-PET COVARIANCE NETWORKS ENHANCE PREDICTION OF RETROSPECTIVE COGNITIVE CHANGE IN ALZHEIMER’S DISEASE Jacob W. Vogel, Niklas Mattsson,

HYPERGLYCEMIA: PREDISPOSITION FOR MICROEMBOLI, STROKE, AND WHITE MATTER CHANGES Leila Parand, Saif Bushnaq, Yue Wang, Lenora Mathes, Dinesh Jillella,

DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS Teemu Paajanen, Shadi Mahdiani, Marie.

Marjolein Bulk, Linda van der Graaf, Walid M

Colin Groot, Chris W. J. van der Weijden, Wiesje M

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline Sander C.J.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Japanese brain bank network for neuroscience research

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Hemodynamic effect of carotid stenting and carotid endarterectomy

Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study Kumar B. Rajan, Jennifer Weuve,

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study Kumar B. Rajan, Jennifer Weuve,

Figure 2 A case of early-onset PSD

LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Charissa Poon, Kullervo Hynynen Alzheimer's.

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective Matthew Baumgart, Heather M. Snyder,

Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Bradley Wyman, Yahong.

Daniel Bos, Meike W. Vernooij, Renée F. A. G. de Bruijn, Peter J

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.

Mark D. Meadowcroft, Douglas G. Peters, Carson J

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

COGNITIVE COMPLAINTS IN OLDER ADULTS AT RISK FOR ALZHEIMER’S DISEASE ARE ASSOCIATED WITH ALTERED RESTING STATE NETWORKS Joey A. Contreras, Joaquín Goñi,

MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Vincent Doré, Pierrick Bourgeat, Luping Zhou, Jurgen Fripp,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS Betty M. Tijms, Mara ten Kate, Sander C.J.

Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people Oskar Hansson, Sebastian Palmqvist,

Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.

Different pathways to Alzheimer’s disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Automated detection of beta-amyloid–related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI

Extracting white matter hyperintensities in Alzheimer's disease risk and aging studies using supervised segmentation methods Vamsi Ithapu, Vikas Singh,

BRAIN AMYLOIDOSIS AND COGNITIVE DECLINE IN MCI: 12-MONTH FOLLOW-UP

Presentation transcript:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association CEREBRAL BLOOD FLOW MEASURED WITH PHASE-CONTRAST MRI IN AD, MCI AND CONTROLS Jolien F. Leijenaar, Ingrid S. van Maurik, Joost Kuijer, Wiesje M. van der Flier, Philip Scheltens, Frederik Barkhof, Niels D. Prins Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 12, Issue 7, (July 2016) DOI: 10.1016/j.jalz.2016.06.138 Copyright © 2016 Terms and Conditions

Figure 1 2D phase-contrast MR image of right (1) and left (2) carotid artery and basilar artery (3). Regions of interest were manually drawn in white. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, DOI: (10.1016/j.jalz.2016.06.138) Copyright © 2016 Terms and Conditions

Figure 2 Bar shows mean cerebral blood flow (CBF) in controls, subjects with mild cognitive complaints (MCI) and subjects with Alzheimer's disease (AD). * p=0.04 compared to controls ** p=0 01 compared to controls. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, DOI: (10.1016/j.jalz.2016.06.138) Copyright © 2016 Terms and Conditions